Landing
American Society of Hematology (ASH) 2025
Real-world clinical characteristics and treatment outcomes in PNH patients prescribed pegcetacoplan across Europe, the United States and Canada
Consistent benefits of pegcetacoplan treatment in PNH patients with and without a history of aplastic anemia in the real world: Analysis of the ongoing Phase 4 COMPLETE observational study
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.